Duality Advisers’s Thermo Fisher Scientific TMO Stock Holding History

Duality Advisers’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-1,241	Closed	-$721K	–	486
2024 Q1	$721K	Sell	1,241 -2,573	-67%	-$1.44M	0.07%	400
2023 Q4	$2.02M	Buy	+3,814	New	+$1.85M	0.21%	170
2022 Q1	–	Sell	-5,669	Closed	-$3.78M	–	823
2021 Q4	$3.78M	Buy	+5,669	New	+$3.54M	0.41%	68
2021 Q2	–	Sell	-10,672	Closed	-$4.87M	–	728
2021 Q1	$4.87M	Sell	10,672 -13,514	-56%	-$6.45M	0.42%	56
2020 Q4	$11.3M	Buy	+24,186	New	+$11.3M	0.84%	10
2020 Q3	–	Sell	-4,143	Closed	-$1.5M	–	650
2020 Q2	$1.5M	Buy	+4,143	New	+$1.39M	0.14%	205
2019 Q4	–	Sell	-2,290	Closed	-$667K	–	439
2019 Q3	$667K	Buy	+2,290	New	+$656K	0.04%	281
2019 Q2	–	Sell	-17,400	Closed	-$4.76M	–	285
2019 Q1	$4.76M	Buy	17,400 +6,140	+55%	+$1.53M	0.28%	107
2018 Q4	$2.52M	Buy	+11,260	New	+$2.64M	0.15%	141

Other funds holding TMO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Duality Advisers's TMO Position: Q2 2024 in Review

Duality Advisers sold out of Thermo Fisher Scientific (TMO) in Q2 2024, closing a stake of 1,241 shares — an estimated $721K sold.

Duality Advisers first reported a position in TMO in Q4 2018 and held it in 9 quarters. The position peaked at $11.3M in Q4 2020. 2,542 funds tracked by Wall St. Rank hold TMO as of Q2 2024.

Duality Advisers reported no remaining Thermo Fisher Scientific position as of Q2 2024 after selling out during the quarter.
Duality Advisers sold 1,241 Thermo Fisher Scientific shares in Q2 2024, an estimated $721K.
Duality Advisers first reported a position in Thermo Fisher Scientific in Q4 2018 and held it in 9 quarters.
Duality Advisers's Thermo Fisher Scientific position peaked at $11.3M in Q4 2020.
2,542 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2024.

Based on Duality Advisers's 13F filing for Q2 2024.